155 related articles for article (PubMed ID: 32811161)
1. LncRNA
Cui R; Liu C; Lin P; Xie H; Wang W; Zhao J; Jiang S; Shi J; Yu X
Epigenomics; 2020 Aug; 12(15):1257-1271. PubMed ID: 32811161
[No Abstract] [Full Text] [Related]
2. Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/
Liu C; Lin P; Zhao J; Xie H; Li R; Yang X; Wang N; Jia H; Jiang S; Zhang K; Yu X
Epigenomics; 2021 Oct; 13(20):1591-1605. PubMed ID: 34657447
[TBL] [Abstract][Full Text] [Related]
3. Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis.
Xie H; Zhao J; Wan J; Zhao J; Wang Q; Yang X; Yang W; Lin P; Yu X
Oncol Rep; 2021 Feb; 45(2):619-629. PubMed ID: 33416179
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
Liu C; Jiang S; Xie H; Jia H; Li R; Zhang K; Wang N; Lin P; Yu X
Med Oncol; 2022 May; 39(5):94. PubMed ID: 35570225
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Zhang K; Liu C; Hu C; Lin P; Qi Q; Jia H; Tang J; Yu X
Heliyon; 2023 Jun; 9(6):e16870. PubMed ID: 37346322
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
8. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.
Xie M; Yu T; Jing X; Ma L; Fan Y; Yang F; Ma P; Jiang H; Wu X; Shu Y; Xu T
Mol Cancer; 2020 Jun; 19(1):112. PubMed ID: 32600329
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2.
Zhou Y; Yang H; Xia W; Cui L; Xu R; Lu H; Xue D; Tian Z; Ding T; Cao Y; Shi Q; He X
J Biochem; 2020 Mar; 167(3):295-301. PubMed ID: 31790140
[TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
11. Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
Moon SJ; Jeong BC; Kim HJ; Lim JE; Kim HJ; Kwon GY; Jackman JA; Kim JH
Theranostics; 2021; 11(2):958-973. PubMed ID: 33391515
[No Abstract] [Full Text] [Related]
12. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
Zhao B; Lu YL; Yang Y; Hu LB; Bai Y; Li RQ; Zhang GY; Li J; Bi CW; Yang LB; Hu C; Lei YH; Wang QL; Liu ZM
Cancer Biomark; 2018 Feb; 21(3):613-620. PubMed ID: 29278879
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
[TBL] [Abstract][Full Text] [Related]
15. A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation.
Cui Y; Lu C; Zhang Z; Mao A; Feng L; Fu L; Gu F; Ma X; He D
Int J Biol Sci; 2020; 16(1):162-171. PubMed ID: 31892853
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Zhang G; He X; Ren C; Lin J; Wang Q
J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression.
Ding J; Li J; Wang H; Tian Y; Xie M; He X; Ji H; Ma Z; Hui B; Wang K; Ji G
Cell Death Dis; 2017 Aug; 8(8):e2997. PubMed ID: 28796262
[TBL] [Abstract][Full Text] [Related]
20. 3'-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells.
Sun Y; Huang YH; Huang FY; Mei WL; Liu Q; Wang CC; Lin YY; Huang C; Li YN; Dai HF; Tan GH
Theranostics; 2018; 8(7):2044-2060. PubMed ID: 29556372
[No Abstract] [Full Text] [Related]
[Next] [New Search]